NasdaqCM:SRTAHealthcare
Strata Critical Medical (SRTA) Q1 Profit Challenges Narrative Of Prolonged Losses
Q1 2026: Revenue Holds Steady While Profitability Remains Tight
Strata Critical Medical (SRTA) opened 2026 with Q1 revenue of US$67.4 million and basic EPS of US$0.03, alongside net income from ongoing operations of US$2.4 million. This set a mixed tone for the latest update. The company has seen quarterly revenue move from US$36.4 million in Q4 2024 to US$67.4 million in Q1 2026. Basic EPS has ranged from a loss of US$0.09 in Q4 2024 to a profit of US$0.03 in the latest quarter, highlighting...